Suppr超能文献

用于评估临床化学检测分析质量的西格玛指标:允许总误差(TEa)目标的重要性。

Sigma metrics used to assess analytical quality of clinical chemistry assays: importance of the allowable total error (TEa) target.

作者信息

Hens Koen, Berth Mario, Armbruster Dave, Westgard Sten

出版信息

Clin Chem Lab Med. 2014 Jul;52(7):973-80. doi: 10.1515/cclm-2013-1090.

Abstract

BACKGROUND

Six Sigma metrics were used to assess the analytical quality of automated clinical chemistry and immunoassay tests in a large Belgian clinical laboratory and to explore the importance of the source used for estimation of the allowable total error. Clinical laboratories are continually challenged to maintain analytical quality. However, it is difficult to measure assay quality objectively and quantitatively.

METHODS

The Sigma metric is a single number that estimates quality based on the traditional parameters used in the clinical laboratory: allowable total error (TEa), precision and bias. In this study, Sigma metrics were calculated for 41 clinical chemistry assays for serum and urine on five ARCHITECT c16000 chemistry analyzers. Controls at two analyte concentrations were tested and Sigma metrics were calculated using three different TEa targets (Ricos biological variability, CLIA, and RiliBÄK).

RESULTS

Sigma metrics varied with analyte concentration, the TEa target, and between/among analyzers. Sigma values identified those assays that are analytically robust and require minimal quality control rules and those that exhibit more variability and require more complex rules. The analyzer to analyzer variability was assessed on the basis of Sigma metrics.

CONCLUSIONS

Six Sigma is a more efficient way to control quality, but the lack of TEa targets for many analytes and the sometimes inconsistent TEa targets from different sources are important variables for the interpretation and the application of Sigma metrics in a routine clinical laboratory. Sigma metrics are a valuable means of comparing the analytical quality of two or more analyzers to ensure the comparability of patient test results.

摘要

背景

六西格玛指标用于评估比利时一家大型临床实验室中自动化临床化学和免疫分析测试的分析质量,并探讨用于估计允许总误差的来源的重要性。临床实验室不断面临维持分析质量的挑战。然而,客观且定量地测量分析质量很困难。

方法

西格玛指标是一个基于临床实验室中使用的传统参数(允许总误差(TEa)、精密度和偏倚)来估计质量的单一数字。在本研究中,计算了五台ARCHITECT c16000化学分析仪上41种血清和尿液临床化学检测项目的西格玛指标。对两种分析物浓度的质控品进行检测,并使用三种不同的TEa目标(里科斯生物变异度、CLIA和RiliBÄK)计算西格玛指标。

结果

西格玛指标随分析物浓度、TEa目标以及分析仪之间而变化。西格玛值确定了那些分析稳健且需要最少质量控制规则的检测项目,以及那些表现出更多变异性且需要更复杂规则的检测项目。基于西格玛指标评估了分析仪之间的变异性。

结论

六西格玛是一种更有效的质量控制方法,但许多分析物缺乏TEa目标以及不同来源的TEa目标有时不一致,是西格玛指标在常规临床实验室中解释和应用的重要变量。西格玛指标是比较两台或更多分析仪分析质量以确保患者检测结果可比性的有价值手段。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验